| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | Mar 11, 2025 | Aquestive Therapeutics, Inc. | Chief Science Officer | Sell | 95.0 | +82,138 | 31.42% | ✗ | $86.6K |
| Mar 9, 2024 | Oct 2, 2024 | Aquestive Therapeutics, Inc. | Chief Science Officer | Sell | 42.5 | -19,505 | -6.94% | ✗ | $95.2K |
| Mar 9, 2024 | Mar 12, 2024 | Aquestive Therapeutics, Inc. | SVP, Research & Development | Sell | 42.5 | -12,956 | -4.78% | ✗ | $63.2K |
| Mar 10, 2023 | Mar 11, 2024 | Aquestive Therapeutics, Inc. | SVP, Research & Development | Sell | 90.0 | +110,519 | 68.90% | ✗ | $1.6K |